We need you! Join our contributor community and become a WikEM editor through our open and transparent promotion process.
Loperamide
From WikEM
Contents
Administration
- Type: Anti-diarrheal, opioid
- Dosage Forms: 1mg, 2mg; 1/5 mL
- Routes of Administration: PO
- Common Trade Names: Imodium, Diamode, Imodium A-D, Imodium A-D EZ Chews, Imodium A-D New Formula, Kao-Paverin, Kaopectate 1-D
Adult Dosing
- Acute Diarrhea:
- 2mg PO per dose
- Start: 4mg PO x1, then 2mg PO after each loose stool; Max: 16mg/day
- 2mg PO per dose
- Chronic Diarrhea
- 4-8mg/day PO divided qd-tid
- Start: 4mg PO x1, then 2mg PO after each loose stool until maint. dose established; Max: 16mg/day
- 4-8mg/day PO divided qd-tid
Pediatric Dosing
- Acute diarrhea:
- 2-5 yo, 13-20 kg
- Dose: 1mg PO x1 after each loose stool
- Max: 3mg/day
- Use OTC 1mg/5 sol or 1mg/7.5 mL susp
- Dose: 1mg PO x1 after each loose stool
- 6-8 yo, 20-30 kg
- Dose: start 2mg PO x1, then 1mg PO after each loose stool
- Max: 4mg/day
- Dose: start 2mg PO x1, then 1mg PO after each loose stool
- 8-11 yo, 30-40 kg
- Dose: start 2mg PO x1, then 1mg PO after each loose stool
- Max: 6mg/day
- Dose: start 2mg PO x1, then 1mg PO after each loose stool
- 12 yo and older
- Dose: start 4mg PO x1, then 2mg PO after each loose stool
- Max: 8mg/day
- Dose: start 4mg PO x1, then 2mg PO after each loose stool
- 2-5 yo, 13-20 kg
- Chronic diarrhea
- 0.08-0.24mg/kg/day PO divided bid-tid
- Max: 2mg/dose
- 0.08-0.24mg/kg/day PO divided bid-tid
Special Populations
- Pregnancy Rating: B
- Lactation risk: Probably safe
Renal Dosing
- Adult:
Hepatic Dosing
- Adult/Pediatric: Reduced first-pass metabolism
- CNS toxicity
Contraindications
- Allergy to class/drug
If given with:
- potassium acid phosphate
- potassium chloride
- potassium citrate
- potassium phosphate
Adverse Reactions
Serious
- toxic megacolon
- paralytic ileus
- angioedema
- anaphylaxis/anaphylactoid reaction
- toxic epidermal necrolysis
- Stevens-Johnson syndrome
- erythema multiforme
- urinary retention
- heat stroke
Common
- constipation
- nausea
- abdominal cramps
- dizziness
Pharmacology
- Half-life: Half-life: 10.8h
- Metabolism: liver; CYP450: 2C8, 3A4 substrate; Info: P-gp substrate; 40% systemic absorption
- Excretion: feces 30%, urine <2%
Mechanism of Action
binds gut wall opioid receptor, inhibiting peristalsis; increases anal sphinctor tone